enVVeno Medical Corporation
NASDAQ:NVNO
5.75 (USD) • At close July 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.031 | 0.03 | 0.042 | 0.083 | 0.031 | 0.175 | 0.028 | 0.039 | 0.18 | 0.305 | 0.295 |
| Cost of Revenue
| 0.141 | 0.134 | 0.138 | 0.138 | 0.136 | 0.13 | 0.133 | 0.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.098 | 0.133 | 0 | 0.189 | 0.212 | 0.397 |
| Gross Profit
| -0.141 | 0.69 | -0.138 | -0.138 | -0.136 | -0.13 | -0.133 | -0.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.031 | 0.03 | 0.042 | 0.083 | 0.031 | 0.077 | -0.105 | 0.039 | -0.008 | 0.093 | -0.101 |
| Gross Profit Ratio
| 0 | 0.837 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0.44 | -3.768 | 1 | -0.047 | 0.305 | -0.343 |
| Reseach & Development Expenses
| 3.052 | 2.981 | 2.798 | 4.214 | 3.595 | 2.797 | 2.492 | 3.073 | 1.552 | 1.782 | 1.225 | 1.09 | 1.632 | 2.277 | 0.758 | 0.706 | 0.511 | 0.788 | 0.677 | 0.428 | 0.313 | 0.293 | 0.425 | 0.28 | 0.24 | 0.349 | 0.043 | 0.185 | 0.073 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.31 | 3.163 | 2.551 | 2.6 | 3.202 | 3.663 | 3.659 | 3.913 | 3.783 | 7.211 | 1.482 | 1.296 | 1.176 | 1.881 | 1.164 | 0.84 | 0.998 | 0.922 | 1.157 | 1.532 | 1.301 | 1.217 | 1.105 | 2.915 | 1.247 | 1.657 | 1.664 | 1.086 | 1.05 | 1.228 | 0.959 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 5.362 | 6.144 | 5.349 | 6.814 | 6.797 | 6.46 | 6.151 | 6.986 | 5.335 | 8.992 | 2.707 | 2.385 | 2.808 | 4.158 | 1.922 | 1.546 | 1.509 | 1.71 | 1.834 | 1.96 | 1.614 | 1.51 | 1.529 | 3.195 | 1.488 | 2.006 | 1.707 | 1.271 | 1.122 | 1.228 | 0.959 |
| Operating Income
| -5.503 | -6.278 | -5.349 | -6.814 | -6.797 | -6.46 | -6.151 | -6.986 | -5.335 | -8.992 | -2.707 | -2.385 | -2.808 | -4.158 | -1.922 | -1.546 | -1.509 | -2.299 | -1.834 | -1.96 | -1.582 | -1.799 | -1.488 | -3.112 | -1.456 | -1.929 | -1.812 | -1.232 | -1.131 | -1.136 | -1.06 |
| Operating Income Ratio
| 0 | -7.619 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.646 | -59.055 | -35.708 | -37.328 | -46.884 | -11.013 | -64.999 | -31.746 | -6.271 | -3.725 | -3.588 |
| Total Other Income Expenses Net
| 0.511 | 0.629 | 0.304 | 0.301 | 0.405 | 0.28 | 0.054 | -0.113 | 0.005 | 0.005 | 0.313 | 0.001 | 0.032 | -0.216 | -0.053 | -0.081 | 0.346 | 0.008 | 0.019 | 0.014 | 0.009 | -0.32 | 0.019 | 0.184 | 1.489 | 0.624 | 0.004 | 0.022 | -0.024 | -0.397 | -0.002 |
| Income Before Tax
| -4.992 | -5.649 | -5.001 | -6.474 | -6.392 | -6.18 | -6.097 | -7.062 | -5.33 | -8.988 | -2.389 | -2.378 | -2.773 | -4.374 | -1.975 | -1.627 | -1.16 | -2.291 | -1.815 | -1.946 | -1.574 | -1.782 | -1.468 | -5.045 | -4.747 | -3.124 | -2.255 | -1.249 | -1.164 | -1.54 | -1.076 |
| Income Before Tax Ratio
| 0 | -6.856 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.371 | -58.487 | -35.24 | -60.523 | -152.824 | -17.839 | -80.878 | -32.188 | -6.454 | -5.052 | -3.643 |
| Income Tax Expense
| 0 | 1.453 | -0.348 | -0.34 | -0.765 | -0.474 | -0.033 | 0.076 | 0 | 0 | -0.317 | -0.007 | -0.003 | -0 | 0.052 | 0.081 | -0.003 | 0.597 | 0.019 | 0.014 | 0.009 | -0.017 | 0 | 0.112 | 0.21 | 0.109 | 0.447 | 0.016 | 0.009 | 0.007 | 0.014 |
| Net Income
| -4.992 | -5.649 | -5.001 | -6.474 | -5.627 | -5.706 | -6.064 | -7.062 | -5.33 | -8.988 | -2.389 | -2.378 | -2.773 | -4.374 | -1.975 | -1.627 | -1.16 | -2.291 | -1.815 | -1.946 | -1.574 | -1.782 | -1.468 | -5.045 | -4.747 | -3.124 | -2.255 | -1.249 | -1.164 | -1.54 | -1.076 |
| Net Income Ratio
| 0 | -6.856 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.371 | -58.487 | -35.24 | -60.523 | -152.824 | -17.839 | -80.878 | -32.188 | -6.454 | -5.052 | -3.643 |
| EPS
| -0.31 | -0.42 | -0.45 | -0.58 | -0.5 | -0.6 | -0.54 | -0.63 | -0.47 | -0.8 | -0.26 | -0.28 | -0.48 | -1.72 | -1.37 | -1.89 | -1.57 | -3.19 | -2.53 | -3.28 | -3.21 | -3.79 | -3.13 | -16.21 | -11.69 | -8.06 | -5.82 | -2.85 | -2.65 | -3.51 | -2.45 |
| EPS Diluted
| -0.31 | -0.42 | -0.45 | -0.58 | -0.5 | -0.6 | -0.54 | -0.63 | -0.47 | -0.8 | -0.26 | -0.28 | -0.48 | -1.72 | -1.37 | -1.89 | -1.57 | -3.19 | -2.53 | -3.28 | -3.21 | -3.79 | -3.13 | -16.21 | -11.69 | -8.06 | -5.82 | -2.85 | -2.65 | -3.51 | -2.45 |
| EBITDA
| -5.362 | -6.144 | -5.515 | -6.977 | -7.021 | -6.566 | -5.997 | -6.74 | -5.206 | -8.871 | -2.899 | -2.278 | -2.705 | -4.062 | -1.771 | -1.361 | -1.422 | -1.597 | -1.711 | -1.85 | -1.482 | -1.446 | -1.454 | -5.084 | -5.993 | -3.606 | -1.779 | -1.219 | -1.094 | -1.095 | -1.02 |
| EBITDA Ratio
| 0 | -7.456 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -47.447 | -47.458 | -34.906 | -60.987 | -192.918 | -20.589 | -63.814 | -31.423 | -6.067 | -3.591 | -3.451 |